The AJMC® Dermatology compendium is a comprehensive resource for clinical news and expert insights for diseases related to the skin, hair, and nails.
April 22nd 2024
A recent study found that patients with actinic keratosis experienced more pain during red light photodynamic therapy (PDT) than simulated daylight PDT, emphasizing the need to understand patient experiences for better treatment decisions.
Therapeutic Advances in Plaque Psoriasis to Address Unmet Needs in Treatment and Improve Patient Outcomes
1.5 Credits / Dermatology
View More
Managed Care Considerations for Management of Molluscum Contagiosum: Examining Emerging Treatments
1.0 Credit / Dermatology
View More
AJMC® Powered by Patients and Managed Care Insights – More Than a Cosmetic Disease: Vitiligo Treatment Approaches and Raising Awareness of the Disease Burden
1.5 Credits / Dermatology
View More
Dr Jonathan Kentley Discusses Training Algorithms to Detect Melanoma
July 16th 2022Many algorithms claiming to identify melanoma better than dermatologists are trained on retrospective datasets, which is not reflective of real-world clinical practice, said Jonathan Kentley, MBBS, MSc, research fellow at Memorial Sloan Kettering Cancer Center.
Watch
Dr Jonathan Kentley: Physicians Are Working Alongside AI, Not Being Replaced by It
June 30th 2022Jonathan Kentley, MBBS, MSc, research fellow at Memorial Sloan Kettering Cancer Center, talks about how dermatologists are working with artificial intelligence (AI) while still making sure patient voices are heard.
Watch
Researchers Outline Use of Hormonal Therapies in Acne, Hidradenitis Suppurativa
June 25th 2022Combined oral contraceptives (COCs) and, more recently, spironolactone, have been identified as options for adolescent females with acne and hidradenitis suppurativa (HS), although varying levels of data are available supporting their use in these patients.
Read More
The FDA approved Eli Lilly’s baricitinib drug to regrow hair in patients with alopecia; the American Medical Association (AMA) adopts resolutions that go against criminalization of abortion; an experimental amyotrophic lateral sclerosis (ALS) therapy under review with the FDA has been approved in Canada.
Read More
Increases in Inflammatory Markers, Leukocyte Profile May Impact HS Severity
May 20th 2022The findings come from a novel longitudinal analysis of 400 patients, which the researchers said validates and further underscores the utility of laboratory parameters for the management of hidradenitis suppurativa.
Read More
European Study Shows High Rate of Skin Conditions, Diseases
April 8th 2022When including patients who had a mole check or cancer screening, the proportion of patients with at least 1 dermatological condition or disease increased to 47%; both non-melanoma and melanoma skin cancers were among the top 12 skin diseases reported in the study.
Read More
Researchers Highlight Special Considerations for Managing HS in Certain Populations
April 2nd 2022As potential new treatment options emerge for hidradenitis suppurativa (HS), an inflammatory condition, researchers emphasized the importance of clinicians being prepared to manage patients that have additional health factors.
Read More
Study Findings Signal Some PE-Backed Dermatology Practices May Not Be Performing Well
March 18th 2022Public financial statements from 9 dermatology groups backed by private equity (PE) were analyzed by the researchers, who described a significant decrease in debt valuations of these groups both before and during the COVID-19 pandemic.
Read More